Fundraising FoxLeaps by Bayer — 2024 Investments
9 investments dated 2024 · listed companies and verified rows first · show all
Accent Therapeutics is a biotechnology company focused on discovering and developing small molecule drugs to improve health outcomes for cancer patients.
BiotechHealthtechLongevity
Co-investorsAtlas VentureDroia VenturesEcoR1 CapitalGV (Google Ventures)The Column GroupAbbVie+3 more
BiotechWatertown, US
Kathy Bergsteinsson(Executive Officer)inKathy Yi(Executive Officer)inJoseph Knowles(Executive Officer, Director)
BoardLucio Iannone(Director)inArjun Goyal(Director)Jill DeSimone(Director)
Co-investorsVida Ventures
BiotechDavis, US
Steven Watkins(Executive Officer, Director, Promoter)inCarlito Lebrilla(Director, Promoter)
Co-investorsArgonautic VenturesiSelect FundAcre Venture PartnersCollaborative FundMitsui & CoMorado Ventures+1 more
NextPoint is a precision therapeutics company developing cancer treatments targeting the B7-H7/HHLA2 axis, including a T-cell engager, an antibody-drug conjugate with proprietary linker technology, and a multi-functional checkpoint inhibitor.
BiotechHealthtechAustin, US
Gordon Freeman(Scientific Founder)XingXing Zang(Scientific Founder)inIvan Cheung(Chief Executive Officer)inLeena Gandhi(Chief Medical Officer)inTatiana Novobrantseva(Chief Scientific Officer)inAxel Hoos(Director)
Co-investorsCatalio Capital Management, LPMPM BioImpactSanofi VenturesCatalio Capital ManagementInvusSixty Degree Capital
Nuvig Therapeutics is a biotech company developing immune-modulating therapies for autoimmune and chronic inflammatory diseases, using an endogenous regulatory mechanism intended to treat inflammation without compromising broader immune function.
BiotechLongevity
Co-investorsSanofi VenturesAlexandriaB CapitalDigitalis VenturesGlobal BioAccess FundMission Biocapital+3 more
One.bio develops food products designed to provide beneficial molecular signals to support health and address chronic inflammatory disease.
BiotechFoodTechHealthtechWellness & Fitness
Matt Amicucci(Co-Founder & Chief Science Officer)Matt Barnard(Co-Founder & CEO)in
Co-investorsAcre Venture PartnersAlpha EdisonBetter Ventures Central LlcCollaborative FundDoon CapitalE12 Venture Capital, Llc+6 more
.png)
Sudo Biosciences develops small molecule therapeutics for neurological and immune-mediated inflammatory conditions.
BiotechHealthtechMedical DevicesMenlo Park, US
Jim Bristol(Director)Daniel Estes(Director)inScott Byrd(Executive Officer, Director)in
Co-investorsFrazier Life SciencesMonograph Capital PartnersPICUS CAPITALSanofi VenturesSV Health InvestorsDementia Discovery Fund+3 more
Summer Health provides text-based, on-demand pediatric care that connects parents with doctors within minutes for their children's non-scheduled health needs.
ConsumerDigital HealthHealthtech
Ellen D.(Founder)inEllen DaSilva(Founder)Matthew Woo(Founder)
Co-investors7wire VenturesCoalition OperatorsCorewell Health VenturesIngeborg InvestmentsLux CapitalSequoia Capital+8 more
Transcarent operates a generative AI-powered health and care platform that combines medical, pharmacy, and point solutions into a single member experience, helping people navigate the healthcare system and access on-demand care.
AI & Machine LearningDigital HealthHealthtechDenver, US
Glen Tullman(Founder)inStephanie Peng(Executive Officer)Lee Shapiro(Executive Officer, Director)Ken Frazier(Director)Holly Maloney(Director)Hemant Taneja(Director)
Co-investors7wire VenturesAlta PartnersCorewell Health VenturesGeneral CatalystGeodesic CapitalGreatPoint Ventures+9 more
.png)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.